Loading insider details...
Beta
Latest Form 4 (Sep 28, 2026): Grant/Award of 2,306 LXEO shares, $6.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 2,306 | $6.1K |
| Aug 19, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 3,345 | $16.6K |
| Jul 1, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 67,000 | n/a |
| May 20, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 3,342 | $16.9K |
| Apr 7, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 55,000 | $313.1K |
| Mar 18, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 2,623 | $6.9K |
| Feb 20, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 10,173 | $64.9K |
| Feb 6, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 161,665 | n/a |
| Nov 20, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Sale | 1,127 | $10.4K |
| Oct 17, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 33,000 | n/a |